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Stimuli-responsive organic/inorganic nanohybrids, with an inorganic core and a stimuli-
responsive polymer coating, have been frequently suggested as a promising drug delivery 
system (DDS), due to their outstanding biocompatibility, versatile surface modification, 
specific responsive properties to external stimuli, etc. Due to the specific magnetic 
responsiveness, magnetic nanoparticles can penetrate body tissues under a magnetic guidance, 
providing a potential platform for magnetic-directed DDS. Furthermore, a sharp local heating can be 
obtained for superparamagnetic nanoparticles when exposed to an alternating magnetic field (AMF). 
This specific property opens up the possibility for application in tumor treatments [2].  
Here, magnetic drug delivery vehicles consisting of maghemite nanoparticles and smart 
poly (vinyl alcohol)-b-poly (acrylic acid) polymer coating were fabricated via electrostatic 
binding. Sharp responsiveness to pH, ionic strength and magnetic field was observed. MTS 
assay with mouse L929 cells showed a good cytocompatibility, and also a good internalization into 
MEL-5 cells as confirmed by Fluorescence microscopy and transmission electronic microscopy. The 
triggered release behavior of uploaded methylene blue (MB) can be achieved by changing pH, 
temperature or ionic strength (IS). A local heating was detected when exposed to external 
AMF (755 kHz, 14 mT) treatment, resulting in a faster release. This kind of drug delivery 
vehicles can be envisaged for controlled release to a specifically urgent physiological need, such 
as tumors, as well as potential treatment of tumors via hyperthermia.  
 
 
Scheme 1. Preparation of maghemite nanohybrids and drug loading (a), and triggered release by 
change in pH, IS, temperature or AMF treatment after internalization into the tumor sites (b).  
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